Radioiodine-131 treatment of thyrotoxicosis: dose required for and some factors affecting the early induction of hypothyroidism

Eur J Nucl Med. 1985;10(9-10):450-4. doi: 10.1007/BF00256589.

Abstract

The results of sodium iodide 131I treatment of thyrotoxicosis in 1,168 patients (302 males, 866 females; 58.5% diffuse and 41.5% multinodular toxic goitre) are presented. At the end of the 1st year post-treatment, 54.4% were hypothyroid, and the incidence of hypothyroidism after the 2nd year increased by 3% per year. When the results were analysed according to the calculated radiation dose the thyroid, it was found that the cumulative incidence of hypothyroidism from 6 months to 2 years post-treatment rose almost proportionally to the dose in cases of doses of 1,500-15,000 rad, but increased very little for higher doses; however, the long-term incidence of hypothyroidism was almost independent of the thyroid dose. Multivariate analysis showed that the results of 131I therapy at 6 months depended also on sex (treatment being more effective in women), the consistency of the thyroid gland and the year of treatment, with the same radiation dose giving a higher incidence of hypothyroidism in patients treated recently, in comparison to those treated early in the period studied. Of the patients treated in the period 1978-1982 (mean dose, 300 microCi/g), 93.5% were cured with a single dose of 131I, and 78% were hypothyroid at 6 months post-treatment.

MeSH terms

  • Adult
  • Aged
  • Female
  • Humans
  • Hyperthyroidism / radiotherapy*
  • Hypothyroidism / etiology*
  • Iodine Radioisotopes / therapeutic use*
  • Male
  • Middle Aged
  • Radiotherapy / adverse effects*
  • Radiotherapy Dosage
  • Thyroid Gland / radiation effects*
  • Time Factors

Substances

  • Iodine Radioisotopes